Brian Chambers delivers blunt warning on the future of pharmacy
There are speeches that politely fill a conference slot, and there are speeches that leave a room sitting in uncomfortable silence afterwards.
Brian Chambers’ address at the Scottish Pharmacy Awards did the latter.
In a sector increasingly exhausted by medicine shortages, collapsing margins and relentless operational pressure, Chambers avoided the easy applause lines. Instead, he delivered a direct challenge to the entire pharmacy supply chain, arguing that many of the problems crippling community pharmacy are not accidental failures at all.
“They are the predictable outcome of a system behaving exactly as it was designed to behave.”
Returning repeatedly to the phrase, “Every system is perfectly designed to get the results it gets,” Brian laid out what many in the sector privately acknowledge but rarely say publicly, that the UK’s medicine supply issues are driven less by physical shortages and more by economic design.
“A lot of what we are calling shortages are not real shortages,” he told the audience.
“The medicine exists. The supply chain exists. What doesn’t exist is the economic incentive to bring it here, or keep it here.”
It was a message that resonated strongly with attendees, partly because it reframed the conversation entirely. Rather than blaming manufacturers, wholesalers, contractors or pharmacists individually, Chambers argued the entire system is locked into behaviours that are rational for survival but damaging collectively.
“The system drives every price as low as possible and then discovers that below a certain level, nobody can afford to supply it,” he said.
“The system runs hot, then it fails, and we act surprised.”
The moment that cut through
Among the strongest moments in the speech was a story Brian shared from LinkedIn only days earlier.
A pharmacist had responded to one of his posts about medicines supply by describing his daily professional goal in brutally simple terms.
“To make sure I don’t dispense at a loss.”
For Brian, that comment captured the tragedy sitting at the centre of modern pharmacy.
“That pharmacist didn’t go to university to become a procurement optimiser,” he said.
“He went to help people. To manage conditions. To prevent hospital admissions. To be a clinician in his community.”
Instead, he argued, the current system forces highly trained healthcare professionals into constant financial firefighting, reducing clinical ambition into a daily exercise in damage limitation.
“We have somehow built a system where the clinical expert in the room is forced to think like a trader.”
“That is not his failure. That is a systemic failure.”
The line landed heavily because it reflected a reality many pharmacy teams now quietly accept as normal.
Across the UK, pharmacy owners and managers increasingly describe spending disproportionate amounts of time navigating reimbursement gaps, sourcing stock and avoiding financial loss on prescriptions. It is operational survivalism dressed up as healthcare delivery.
A different model already exists
Brian was careful not to present the situation as hopeless.
In fact, much of the speech focused on pharmacies already proving another future is possible.
Referencing discussions at the Pharmacy Business Conference the previous week, he highlighted one pharmacy business that openly shared its numbers on stage.
Ten percent of its time was spent delivering NHS and private clinical services, yet that activity generated 100% of the business’s profit.
Meanwhile, 90% of its time remained tied up in dispensing, which was operating at a loss.
For Brian, that example represented more than financial diversification. It represented pharmacy moving closer to the role many believe it should have always occupied.
“That is the destination,” he said.
“A pharmacy that is genuinely clinical. That earns its income from outcomes.”
“One that frees the pharmacist to do what they trained to do.”
Importantly, Brian did not argue that dispensing should become unviable or unsupported.
“Nobody should be dispensing at a loss,” he said plainly.
But he questioned why the system continues to reward volume mechanics more heavily than clinical impact, despite years of policy rhetoric around prevention, access and community care.
Why Scotland matters
A significant part of Brians’ speech focused on Scotland’s position within the wider pharmacy landscape.
Unlike many healthcare initiatives elsewhere in the UK, Scotland’s Pharmacy First model is no longer experimental. It is embedded, widely recognised and heavily utilised.
“Thirty five percent of the Scottish population used Pharmacy First last year,” Brian noted.
“That is proof that when pharmacy is given the space and support to be clinical, people come, communities use it, and it delivers.”
That point carried added weight during an evening dedicated to recognising pharmacy excellence across Scotland.
For Brian, the award winners in the room represented something important, not merely resilience, but evidence that parts of the profession are already operating ahead of the wider system around them.
“They didn’t wait for the system to be fixed,” he said.
“They did it anyway.”
The wider conversation pharmacy has been avoiding
Brians’ comments also reflect a growing shift in tone across the sector.
Over the past year, industry conversations around medicines supply and pharmacy sustainability have become increasingly candid. Contractors, wholesalers and manufacturers alike have spoken more openly about the economic pressures sitting underneath supply disruption.
What once might have been discussed quietly behind closed doors is now being acknowledged publicly, particularly as pharmacies continue to absorb rising operational costs while expanding clinical expectations.
That honesty appears to be part of what made Brians’ speech resonate so strongly.
Following the address, two pharmacy owners approached him directly.
“They looked almost bewildered,” he recalled.
‘You could have said anything up there. Why did you say that?’
His response was simple.
“This is not a pharmacy problem. Not a wholesale problem. Not a manufacturing problem.”
“It is our problem. All of us.”
Defining pharmacy’s future
The speech ultimately landed on a challenge rather than a criticism.
Brian argued that the future of pharmacy will not be determined by the current funding model alone, but by the people already pushing beyond its limitations.
“The future of pharmacy is not going to be defined by the system as it stands today,” he concluded.
“It is going to be defined by the people who are already operating beyond it.”
In a profession often trapped between political promises and economic reality, it was a speech that refused to offer easy optimism.
But it did offer something perhaps more useful.
Honesty.
